In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.
Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.